GT BIOPHARMA, INC. (GTBP) Shareholders’ equity 2010–2020
GT BIOPHARMA, INC. (GTBP) shareholders’ equity at each fiscal year-end, per SEC filings.
-$29.4MFY2020 · since FY2010: -$5.5M → -$29.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | -$29.4M | -52.4% |
| FY2019 | -$19.3M | — |
| FY2017 | $251.7M | +1430.0% |
| FY2016 | -$18.9M | +62.6% |
| FY2015 | -$50.6M | -71.0% |
| FY2014 | -$29.6M | -366.9% |
| FY2013 | -$6.3M | +0.0% |
| FY2012 | -$6.3M | -24.2% |
| FY2011 | -$5.1M | +6.7% |
| FY2010 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice